Your browser doesn't support javascript.
loading
Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer.
Wang, Kai-Jian; Wang, Chao; Dai, Li-He; Yang, Jun; Huang, Hai; Ma, Xiao-Jing; Zhou, Zhe; Yang, Ze-Yu; Xu, Wei-Dong; Hua, Mei-Mian; Lu, Xin; Zeng, Shu-Xiong; Wang, Hui-Qing; Zhang, Zhen-Sheng; Cheng, Yan-Qiong; Liu, Dan; Tian, Qin-Qin; Sun, Ying-Hao; Xu, Chuan-Liang.
Afiliación
  • Wang KJ; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Wang C; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Dai LH; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Yang J; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Huang H; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Ma XJ; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.
  • Zhou Z; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Yang ZY; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Xu WD; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Hua MM; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Lu X; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Zeng SX; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Wang HQ; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Zhang ZS; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Cheng YQ; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Liu D; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Tian QQ; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
  • Sun YH; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China. xuchuanliang@vip.126.com sunyhsmmu@126.com.
  • Xu CL; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China. xuchuanliang@vip.126.com sunyhsmmu@126.com.
Clin Cancer Res ; 25(3): 1070-1086, 2019 02 01.
Article en En | MEDLINE | ID: mdl-30397177
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Neoplasias de la Vejiga Urinaria / Cisplatino / Resistencia a Antineoplásicos / Comunicación Autocrina Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Neoplasias de la Vejiga Urinaria / Cisplatino / Resistencia a Antineoplásicos / Comunicación Autocrina Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: China